HPG
Harvest Portfolios Group Portfolio holdings
AUM
$4.3B
This Quarter Return
+5.91%
1 Year Return
+16.34%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2.18B
AUM Growth
+$2.18B
(+7%)
Cap. Flow
+$38.5M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
233
New
10
Increased
121
Reduced
81
Closed
18
Top Buys
| 1 |
Texas Instruments
TXN
|
$20.6M |
| 2 |
ServiceNow
NOW
|
$20.5M |
| 3 |
Citigroup
C
|
$17M |
| 4 |
Elevance Health
ELV
|
$8.53M |
| 5 |
Danaher
DHR
|
$7.34M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$21M |
| 2 |
Intel
INTC
|
$20.1M |
| 3 |
Visa
V
|
$16.4M |
| 4 |
Intuitive Surgical
ISRG
|
$15.3M |
| 5 |
Bank of America
BAC
|
$14.4M |
Sector Composition
| 1 | Healthcare | 49.03% |
| 2 | Technology | 19.86% |
| 3 | Financials | 7.5% |
| 4 | Consumer Discretionary | 6.32% |
| 5 | Communication Services | 5.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $72.2M | 3.31% | 150,226 +14,920 | +11% | +$7.17M |
|
2
Johnson & Johnson
JNJ
$427B
| $71.2M | 3.27% | 430,369 +13,438 | +3% | +$2.22M |
|
3
Stryker
SYK
$150B
| $54.5M | 2.5% | 178,709 -4,337 | -2% | -$1.32M |
|
4
Boston Scientific
BSX
$156B
| $53.8M | 2.47% | 993,780 -37,081 | -4% | -$2.01M |
|
|
5
Intuitive Surgical
ISRG
$170B
| $53.2M | 2.44% | 155,700 -44,636 | -22% | -$15.3M |
|
6
Merck
MRK
$210B
| $53.2M | 2.44% | 461,265 -19,998 | -4% | -$2.31M |
|
|
7
Elevance Health
ELV
$71.8B
| $52.9M | 2.43% | 119,078 +19,189 | +19% | +$8.53M |
|
|
8
Eli Lilly
LLY
$657B
| $52.8M | 2.42% | 112,675 -44,842 | -28% | -$21M |
|
9
Zoetis
ZTS
$69.3B
| $52.2M | 2.4% | 303,203 -6,237 | -2% | -$1.07M |
|
|
10
Danaher
DHR
$147B
| $52.1M | 2.39% | 216,953 +30,584 | +16% | +$7.34M |
|
11
Abbott
ABT
$231B
| $51.5M | 2.36% | 472,000 +27,282 | +6% | +$2.97M |
|
12
AstraZeneca
AZN
$248B
| $50.9M | 2.34% | 711,810 -60,978 | -8% | -$4.36M |
|
13
Medtronic
MDT
$119B
| $50.1M | 2.3% | 568,593 -25,687 | -4% | -$2.26M |
|
14
Amgen
AMGN
$155B
| $50.1M | 2.3% | 225,536 +22,260 | +11% | +$4.94M |
|
15
Regeneron Pharmaceuticals
REGN
$61.5B
| $49.8M | 2.28% | 69,261 +4,504 | +7% | +$3.24M |
|
16
Pfizer
PFE
$141B
| $49.7M | 2.28% | 1,354,542 +185,400 | +16% | +$6.8M |
|
17
Novartis
NVS
$245B
| $49.4M | 2.27% | 489,538 -56,051 | -10% | -$5.66M |
|
18
Bristol-Myers Squibb
BMY
$96B
| $49.3M | 2.26% | 770,520 +65,324 | +9% | +$4.18M |
|
19
Thermo Fisher Scientific
TMO
$186B
| $49.2M | 2.26% | 94,223 +7,231 | +8% | +$3.77M |
|
20
AbbVie
ABBV
$372B
| $48.5M | 2.23% | 359,982 +24,690 | +7% | +$3.33M |
|
21
Apple
AAPL
$3.45T
| $39.2M | 1.8% | 201,995 -15,105 | -7% | -$2.93M |
|
22
Accenture
ACN
$162B
| $38.7M | 1.78% | 125,548 +5,437 | +5% | +$1.68M |
|
23
Microsoft
MSFT
$3.77T
| $38.3M | 1.76% | 112,526 -18,166 | -14% | -$6.19M |
|
24
Alphabet (Google) Class A
GOOGL
$2.57T
| $37.4M | 1.72% | 312,632 -22,336 | -7% | -$2.67M |
|
|
25
Texas Instruments
TXN
$184B
| $36.7M | 1.68% | 203,717 +114,574 | +129% | +$20.6M |
|